Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity

Kidney International

Volumn 62, Issue 1, 2002, Pages 20-30

  Chul, Woo Yang ^a   Hee, Jong Ahn ^a   Wan, Young Kim ^a   Li, Can ^a   Hyung, Wook Kim ^a   Bum, Soon Choi ^a   Jung, Ho Cha ^a   Yong, Soo Kim ^a   Kim, Jin ^a   Byung, Kee Bang ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Chronic allograft nephropathy; Immunosuppression; Nephrotoxicity; Progressive renal failure; Transplantation

Indexed keywords

CYCLOSPORIN A; MESSENGER RNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OSTEOPONTIN; RENIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DISEASE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DRUG WITHDRAWAL; GLOMERULUS; HISTOPATHOLOGY; KIDNEY ARTERY; KIDNEY FIBROSIS; KIDNEY FUNCTION; MALE; NEPHROTOXICITY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SODIUM RESTRICTION;

EID: 0036315487     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00400.x     Document Type: Article

References (38)

1. Cyclosporine-associated chronic nephropathy
2. Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation
3. Chronic cyclosporine nephrotoxicity: The Achilles' heel of immunosuppressive therapy
4. Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy
5. Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporin nephropathy: Role of sodium intake
6. Chronic cyclosporin-induced nephropathy in the rat
7. Cyclosporin A nephropathy: Standardization of the evaluation of kidney biopsies
8. Influence of renin-angiotensin system on epidermal growth factor expression in normal and cyclosporine-treated rat kidney
9. Role of transforming growth factor-beta1 in experimental chronic cyclosporine nephropathy
10. Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin
11. Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis
12. Accelerated apoptosis characterizes cyclosporine associated interstitial fibrosis: Potential role of angiotensin II, nitric oxide and renal ischemia
13. Mycophenolate mofetil, a rationally designed immunosuppressive drug
14. Effects of mycophenolic acid mofetil on acute rejection of kidney allografts in rats
15. Mycophenolic acid inhibits PDGF-induced osteopontin expression in rat mesangial cells
16. Sequential cytokine expression in renal allografts in rats immunosuppressed with maintenance cyclosporine or mycophenolate mofetil
17. Mycophenolate mofetil attenuates renal injury in the rat remnant kidney
18. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats
19. Donor treatment with mycophenolate mofetil: Protection against ischemia-reperfusion injury in the rat
20. A novel approach to the treatment of chronic allograft nephropathy
21. Low-dose cyclosporine and mycophenolate mofetil in renal allograft recipients with suboptimal renal function
22. Mycophenolate mofetil prevents the progression of chronic kidney allograft nephropathy
23. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy
24. Angiotensin II blockade decreases TGF-β1 and matrix proteins in cyclosporine nephropathy
25. Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR)
26. A functional role of osteopontin in experimental crescentic glomerulonephritis in the rat
27. Mycophenolic acid: A new approach to the therapy of experimental mesangial proliferative glomerulonephritis
28. Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion
29. Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney
30. Antiinflammatory properties of mycophenolate mofetil in murine endotoxemia: Inhibition of TNF-alpha and upregulation of IL-10 release
31. Cyclosporine arteriolopathy: Effects of drug withdrawal
32. Mycophenolate mofetil treatment reduces cholesterol-induced atherosclerosis in the rabbit
33. Effects of RS61443 on functional and morphological changes in chronically rejecting rat kidney allografts
34. Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril
35. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure
36. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition
37. Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation
38. A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD 25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function